Alejandro
Martín García Sancho
University of Chicago
Chicago, Estados UnidosPublications in collaboration with researchers from University of Chicago (1)
2022
-
Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies
European Journal of Cancer, Vol. 174, pp. S31-S32